United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic - 23/07/20
Doi : 10.1016/j.jaad.2020.04.049
John A. Zic, MD a, ⁎ 
, Weiyun Ai, MD b, Oleg E. Akilov, MD, PhD c, Joi B. Carter, MD d, Madeleine Duvic, MD e, Francine Foss, MD f, Michael Girardi, MD g, Alejandro A. Gru, MD h, Ellen Kim, MD i, Amy Musiek, MD j, Elise A. Olsen, MD k, Stefan M. Schieke, MD l, Michi Shinohara, MD m, Jasmine M. Zain, MD n, Larisa J. Geskin, MD o, ⁎
, Weiyun Ai, MD b, Oleg E. Akilov, MD, PhD c, Joi B. Carter, MD d, Madeleine Duvic, MD e, Francine Foss, MD f, Michael Girardi, MD g, Alejandro A. Gru, MD h, Ellen Kim, MD i, Amy Musiek, MD j, Elise A. Olsen, MD k, Stefan M. Schieke, MD l, Michi Shinohara, MD m, Jasmine M. Zain, MD n, Larisa J. Geskin, MD o, ⁎ a Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee
b Division of Hematology/Oncology, University of California San Francisco, San Francisco, California
c Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
d Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
e Department of Dermatology, MD Anderson Cancer Center, Houston, Texas
f Division of Hematology/Oncology, Yale-New Haven Medical Center, New Haven, Connecticut
g Department of Dermatology, Yale-New Haven Medical Center, New Haven, Connecticut
h Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia
i Department of Dermatology, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania
j Division of Dermatology, Washington University in Saint Louis, St Louis, Missouri
k Department of Dermatology, Duke University School of Medicine, Durham, North Carolina
l Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin
m Department of Dermatology, University of Washington Medical Center, Seattle, Washington
n Division of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California
o Department of Dermatology, Columbia University Irving Medical Center, New York, New York
∗Correspondence to: John A. Zic, MD, Vanderbilt Dermatology, One Hundred Oaks 719 Thompson Lane, Suite 26300, Nashville, TN 37204-3609.Vanderbilt DermatologyOne Hundred Oaks 719 Thompson LaneSuite 26300NashvilleTN37204-3609∗Larisa Geskin, MD, 161 Fort Washington Avenue, 12th Floor, New York, NY 10032.161 Fort Washington Avenue12th FloorNew YorkNY10032
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : COVID-19, cutaneous lymphoma, high-risk, mycosis fungoides, Sézary syndrome
Abbreviations used : MF, PC, UV
Le texte complet de cet article est disponible en PDF.
Plan
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
Publié par Elsevier Masson SAS.
Vol 83 - N° 2
P. 703-704 - août 2020 Retour au numéro
Article précédent
- Ethical implications of optimizing presentation of expected treatment outcomes
- Jane M. Grant-Kels
- Head and neck surgery is a high-risk procedure for COVID-19 transmission, and there is a need for a preventive strategy to protect professionals
- Ignacio Garcia-Doval
Bienvenue sur EM-consulte, la référence des professionnels de santé.